Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MS&D reveals nonpeptide tachykinin antagonists

July 9, 1997

New antioxidants from Shiseido

July 9, 1997

First launch for antidepressant from Pharmacia & Upjohn

July 8, 1997

IVAX's generic estazolam cleared for marketing by FDA

July 8, 1997

New introduction for Ultiva

July 8, 1997

Royce Laboratories' generic meperidine approved by FDA

July 8, 1997

MS&D discloses selective 5-HT1D agonists

July 8, 1997

AHP discloses agents useful for disorders of the dopaminergic system

July 8, 1997

Effects of befloxatone on psychomotor performance and memory in the elderly

July 7, 1997

Preliminary efficacy and safety studies with panamesine in schizophrenia

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...